000 01737 a2200541 4500
005 20250516115331.0
264 0 _c20130307
008 201303s 0 0 eng d
022 _a1532-1827
024 7 _a10.1038/bjc.2012.475
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDarb-Esfahani, S
245 0 0 _aThymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer.
_h[electronic resource]
260 _bBritish journal of cancer
_cNov 2012
300 _a1892-900 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aBreast Neoplasms
_xchemistry
650 0 4 _aCell Line, Tumor
650 0 4 _aClinical Trials, Phase III as Topic
650 0 4 _aEstrogen Receptor alpha
_xanalysis
650 0 4 _aFemale
650 0 4 _aGene Expression Profiling
650 0 4 _aHumans
650 0 4 _aLogistic Models
650 0 4 _aRNA, Messenger
_xanalysis
650 0 4 _aReceptor, ErbB-2
_xanalysis
650 0 4 _aReceptors, Progesterone
_xanalysis
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aThymosin
_xgenetics
700 1 _aKronenwett, R
700 1 _avon Minckwitz, G
700 1 _aDenkert, C
700 1 _aGehrmann, M
700 1 _aRody, A
700 1 _aBudczies, J
700 1 _aBrase, J C
700 1 _aMehta, M K
700 1 _aBojar, H
700 1 _aAtaseven, B
700 1 _aKarn, T
700 1 _aWeiss, E
700 1 _aZahm, D M
700 1 _aKhandan, F
700 1 _aDietel, M
700 1 _aLoibl, S
773 0 _tBritish journal of cancer
_gvol. 107
_gno. 11
_gp. 1892-900
856 4 0 _uhttps://doi.org/10.1038/bjc.2012.475
_zAvailable from publisher's website
999 _c22196148
_d22196148